{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:35:24Z","timestamp":1794969324033,"version":"4.9.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To characterize scotomas in macular telangiectasia Type 2 (MacTel).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Five of the 27 centers performed microperimetry as part of the MacTel Natural History Observation Study. Data were analyzed in the Moorfields Eye Hospital Reading Centre. The number of stimuli under a threshold of 12, 10, 8, and &lt;0 dB were counted (<jats:italic toggle=\"yes\">thresholding<\/jats:italic>) and compared with one another.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 565 examinations were gradable, received from 632 eyes of 322 participants (age 61.1 \u00b1 9.1 years, 62% females). The authors found absolute scotomas in 243 eyes (43%), 98% of these affected the temporal quadrant, and 99.5% were unifocal. Growth of absolute scotomas was limited to an extent of approximately 40 deg<jats:sup>2<\/jats:sup>. Although transition from functionally unimpaired retina to absolute scotomas is generally steeply sloped, the larger a scotoma, the steeper it is.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Scotoma features were consistent throughout a large MacTel cohort. The temporal quadrant was confirmed as predominantly affected, which might result from vascular or metabolic asymmetry. Functional loss did not exceed an area of 5\u00b0 \u00d7 8\u00b0 however advanced the disorder. Different MacTel phenotypes seem likely and point toward different types of progression; identifying these would improve planning for clinical trials and might lead to better understanding patient outcome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000001693","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T20:56:32Z","timestamp":1495572992000},"page":"S14-S19","source":"Crossref","is-referenced-by-count":17,"title":["SCOTOMA CHARACTERISTICS IN MACULAR TELANGIECTASIA TYPE 2"],"prefix":"10.1097","volume":"38","author":[{"given":"Stela","family":"Vujosevic","sequence":"first","affiliation":[{"name":"The International Microperimetry Reading Centre, Padova, Italy;"},{"name":"Department of Ophthalmology, University of Padova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjebo F. C.","family":"Heeren","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, United Kingdom;"},{"name":"University Eye Hospital, Bonn, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Florea","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Leung","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pauleikhoff","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, St Franziskus Hospital, Munster, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Sallo","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Bird","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, United Kingdom;"},{"name":"Centre for Public Health, Queen's University Belfast, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the MacTel Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","article-title":"Macular telangiectasia type 2","volume":"34","author":"Charbel Issa","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1167\/iovs.06-1272","article-title":"Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia","volume":"48","author":"Charbel Issa","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1167\/iovs.08-2032","article-title":"Reading performance is reduced by parafoveal scotomas in patients with macular telangiectasia type 2","volume":"50","author":"Finger","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1167\/iovs.15-16915","article-title":"Progression of vision loss in macular telangiectasia type 2","volume":"56","author":"Heeren","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/IAE.0000000000000082","article-title":"First symptoms and their age of onset in macular telangiectasia type 2","volume":"34","author":"Heeren","year":"2014","journal-title":"Retina"},{"key":"R6-20230816","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1167\/iovs.12-10580","article-title":"\u201cEn face\u201d OCT imaging of the IS\/OS junction line in type 2 idiopathic macular telangiectasia","volume":"53","author":"Sallo","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1076\/noph.27.1.79.14298","article-title":"Reading disorders due to visual field defects: a neuro-ophthalmological view","volume":"27","author":"Trauzettel-Klosinski","year":"2002","journal-title":"Neuro-Ophthalmology"},{"key":"R8-20230816","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.ophtha.2009.12.044","article-title":"Normal values for fundus perimetry with the microperimeter MP1","volume":"117","author":"Midena","year":"2010","journal-title":"Ophthalmology"},{"key":"R9-20230816","doi-asserted-by":"crossref","first-page":"e12864","DOI":"10.1371\/journal.pone.0012864","article-title":"Structure-function correlation of the human central retina","volume":"5","author":"Charbel Issa","year":"2010","journal-title":"PLoS One"},{"key":"R10-20230816","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1167\/iovs.12-10765","article-title":"The IS\/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia","volume":"53","author":"Sallo","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-20230816","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2007.08.028","article-title":"Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia","volume":"145","author":"Charbel Issa","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R12-20230816","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bjo.2007.131409","article-title":"Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry","volume":"92","author":"Maruko","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R13-20230816","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.126.3.330","article-title":"Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia","volume":"126","author":"Schmitz-Valckenberg","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ajo.2009.04.030","article-title":"Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry","volume":"148","author":"Wong","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.ophtha.2013.04.013","article-title":"Loss of Muller's cells and photoreceptors in macular telangiectasia type 2","volume":"120","author":"Powner","year":"2013","journal-title":"Ophthalmology"},{"key":"R16-20230816","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/09286586.2013.766757","article-title":"Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3","volume":"20","author":"Clemons","year":"2013","journal-title":"Ophthalmic Epidemiol"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08820530490882896","article-title":"Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study","volume":"19","author":"Midena","year":"2004","journal-title":"Semin Ophthalmol"},{"key":"R18-20230816","first-page":"4955","article-title":"Functional and structural measures of disease severity from a phase 1 clinical trial in type 2 idiopathic macular telangiectasia","volume":"57","author":"Sallo","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-20230816","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/bjophthalmol-2015-307064","article-title":"Retinal sensitivity in subjects with type 2 diabetes mellitus: sankara nethralaya diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS II, report no. 4)","volume":"100","author":"Gella","year":"2015","journal-title":"Br J Ophthalmology"},{"key":"R20-20230816","doi-asserted-by":"crossref","first-page":"e24268","DOI":"10.1371\/journal.pone.0024268","article-title":"Identification of a potential susceptibility locus for macular telangiectasia type 2","volume":"7","author":"Parmalee","year":"2012","journal-title":"PLoS One"},{"key":"R21-20230816","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0306-4522(88)90021-8","article-title":"The lengths of the fibres of henle in the retina of macaque monkeys: implications for vision","volume":"25","author":"Perry","year":"1988","journal-title":"Neuroscience"},{"key":"R22-20230816","first-page":"746","article-title":"The histogenesis of the fovea in the macaque monkey","volume":"15","author":"Hendrickson","year":"1976","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-20230816","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1016\/j.visres.2007.01.007","article-title":"The length of henle fibers in the human retina and a model of ganglion receptive field density in the visual field","volume":"47","author":"Drasdo","year":"2007","journal-title":"Vision Res"},{"key":"R24-20230816","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2016.05.007","article-title":"Retinal sensitivity at the junctional zone of eyes with geographic atrophy due to age-related macular degeneration","volume":"168","author":"Hariri","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R25-20230816","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/IAE.0b013e31816d81aa","article-title":"Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia","volume":"28","author":"Helb","year":"2008","journal-title":"Retina"},{"key":"R26-20230816","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/IAE.0b013e3181e096dd","article-title":"Macular telangiectasia: patterns of distribution of macular pigment and response to supplementation","volume":"30","author":"Zeimer","year":"2010","journal-title":"Retina"},{"key":"R27-20230816","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/IAE.0000000000000863","article-title":"Very early disease manifestations of macular telangiectasia type 2","volume":"36","author":"Charbel Issa","year":"2016","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006982-201801001-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T23:03:57Z","timestamp":1692227037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201801001-00004"}},"subtitle":["MacTel Project Report No. 7\u2014The MacTel Research Group"],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000001693","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}